ClinicalTrials.Veeva

Menu

Pilot Study of reSET-O to Treatment-as-usual in Acute Care Settings

Johns Hopkins University logo

Johns Hopkins University

Status

Terminated

Conditions

Opioid-use Disorder

Treatments

Device: reSET-O app

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT04817267
IRB00282938

Details and patient eligibility

About

This randomized controlled pilot study will evaluate feasibility, acceptability, and potential efficacy of an app, reSET-O, for patients being started on buprenorphine in acute care settings.

Full description

This randomized controlled pilot study will enroll 60 participants, who will be randomly assigned to a treatment as usual (TAU) group or a reSET-O+TAU group after being started on buprenorphine in acute care settings (e.g., emergency department) and referred to community treatment. Study enrollment will last for 3 months after discharge from the acute care setting. Participants in the reSET-O+TAU group will be provided with the reSET-O app and will be encouraged to engage with the app for the 3 months following discharge from the acute care unit. The app works as an extension of cognitive behavioral therapy, providing psychoeducation related to opioid use disorder. All participants will be assessed at study intake and every month during the 3-month intervention.

Enrollment

8 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18-65 years old
  • Opioid use disorder
  • Eligible for buprenorphine treatment
  • Has reSET-O compatible mobile device

Exclusion criteria

  • Pregnancy
  • Significant psychiatric comorbidity

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

8 participants in 2 patient groups

reSET-O + Treatment-As-Usual (TAU)
Experimental group
Description:
Participants randomly assigned to this group will receive the TAU plus the reSET-O app.
Treatment:
Device: reSET-O app
Treatment-As-Usual (TAU)
No Intervention group
Description:
Participants randomly assigned to this group will receive the TAU only (no use of the reSET-O app).

Trial contacts and locations

1

Loading...

Central trial contact

August Holtyn

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems